Penumbra Inc (PEN)
244.84
+4.35
(+1.81%)
USD |
NYSE |
Nov 22, 16:00
244.84
0.00 (0.00%)
After-Hours: 20:00
Penumbra Shareholders Equity (Quarterly): 1.104B for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 1.104B |
| June 30, 2024 | 1.161B |
| March 31, 2024 | 1.204B |
| December 31, 2023 | 1.179B |
| September 30, 2023 | 1.104B |
| June 30, 2023 | 1.067B |
| March 31, 2023 | 1.024B |
| December 31, 2022 | 998.86M |
| September 30, 2022 | 973.75M |
| June 30, 2022 | 970.02M |
| March 31, 2022 | 959.30M |
| December 31, 2021 | 953.93M |
| September 30, 2021 | 690.94M |
| June 30, 2021 | 678.93M |
| March 31, 2021 | 655.09M |
| December 31, 2020 | 641.50M |
| September 30, 2020 | 622.41M |
| June 30, 2020 | 624.79M |
| March 31, 2020 | 488.93M |
| December 31, 2019 | 485.89M |
| Date | Value |
|---|---|
| September 30, 2019 | 467.33M |
| June 30, 2019 | 454.09M |
| March 31, 2019 | 436.73M |
| December 31, 2018 | 422.24M |
| September 30, 2018 | 409.42M |
| June 30, 2018 | 425.20M |
| March 31, 2018 | 414.92M |
| December 31, 2017 | 400.41M |
| September 30, 2017 | 383.83M |
| June 30, 2017 | 372.98M |
| March 31, 2017 | 373.47M |
| December 31, 2016 | 266.55M |
| September 30, 2016 | 253.85M |
| June 30, 2016 | 247.59M |
| March 31, 2016 | 238.05M |
| December 31, 2015 | 232.52M |
| September 30, 2015 | 228.59M |
| June 30, 2015 | 100.37M |
| December 31, 2014 | -12.37M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
485.89M
Minimum
Dec 2019
1.204B
Maximum
Mar 2024
879.37M
Average
964.66M
Median
Shareholders Equity (Quarterly) Benchmarks
| Boston Scientific Corp | 20.71B |
| Repligen Corp | 2.017B |
| Inari Medical Inc | 434.76M |
| Bruker Corp | 1.807B |
| QuidelOrtho Corp | 3.187B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.479B |
| Total Liabilities (Quarterly) | 374.84M |
| Current Ratio | 5.821 |